These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7040196)

  • 1. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic extraction of insulin in non-insulin dependent diabetes. Comparative study of obese and non-obese patients.
    Snehalatha C; Mohan V; Ramachandran A; Jayashree R; Viswanathan M
    Diabete Metab; 1984 Sep; 10(3):175-80. PubMed ID: 6386556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
    Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
    Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide response to glucagon in young diabetics.
    Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic beta cell function in offspring of conjugal diabetic parents. Assessment by IRI and C-peptide ratio.
    Snehalatha C; Mohan V; Ramachandran A; Jayashree R; Viswanathan M
    Horm Metab Res; 1984 Dec; 16 Suppl 1():142-4. PubMed ID: 6398253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
    Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
    Vannini P; Ciavarella A; Flammini M; Forlani G; Capelli M; Cocchi V
    Int J Obes; 1982; 6(4):327-34. PubMed ID: 6752059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin metabolism in hypothalamic obesity.
    Blatniczky L; Kautzky L; Péter F
    Exp Clin Endocrinol; 1990 Sep; 96(1):83-9. PubMed ID: 2279530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variation in blood sugar and serum insulin in response to glucose and/or glucagon in healthy subjects.
    Melani F; Verrillo A; Marasco M; Rivellese A; Osorio J; Bertolini MG
    Horm Metab Res; 1976 Mar; 8(2):85-8. PubMed ID: 944163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.